$CALC
CalciMedica, Inc.

2023 Q1 Form 10-K Financial Statement

#000095017023006795 Filed on March 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $15.85M $6.435M $19.10M
YoY Change 284.06% 45.16% 12.09%
% of Gross Profit
Research & Development $6.491M $749.0K $14.11M
YoY Change 195.05% -82.45% -25.34%
% of Gross Profit
Depreciation & Amortization $13.00K $0.00 $300.0K
YoY Change -89.34% -100.0% -42.2%
% of Gross Profit
Operating Expenses $22.30M $7.184M $36.18M
YoY Change 913.64% -17.43% 0.65%
Operating Profit -$22.34M -$36.18M
YoY Change 430.52% 0.65%
Interest Expense $3.170M $309.0K $575.0K
YoY Change 8957.14% 1088.46% 356.35%
% of Operating Profit
Other Income/Expense, Net $3.052M $6.369M
YoY Change 425.3%
Pretax Income -$19.29M -$7.403M -$35.61M
YoY Change 90.07% -14.66% -0.6%
Income Tax $0.00 $1.000K
% Of Pretax Income
Net Earnings -$19.29M -$7.403M -$35.61M
YoY Change 90.05% -14.66% -0.6%
Net Earnings / Revenue
Basic Earnings Per Share -$23.43 -$1.66
Diluted Earnings Per Share -$23.43 -$0.34 -$1.66
COMMON SHARES
Basic Shares Outstanding 22.00M 21.56M 21.49M
Diluted Shares Outstanding 823.1K 21.49M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $34.20M $39.13M $39.13M
YoY Change -38.13% -38.55% -38.55%
Cash & Equivalents $24.39M $17.30M $17.30M
Short-Term Investments $9.800M $21.82M $21.82M
Other Short-Term Assets $300.0K $542.0K $503.0K
YoY Change -89.8% -59.94% -85.15%
Inventory
Prepaid Expenses $503.0K
Receivables
Other Receivables
Total Short-Term Assets $34.50M $39.67M $39.67M
YoY Change -40.75% -40.86% -40.86%
LONG-TERM ASSETS
Property, Plant & Equipment $134.0K $0.00 $0.00
YoY Change -94.26% -100.0% -100.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Total Long-Term Assets $171.0K $0.00 $0.00
YoY Change -92.77% -100.0% -100.0%
TOTAL ASSETS
Total Short-Term Assets $34.50M $39.67M $39.67M
Total Long-Term Assets $171.0K $0.00 $0.00
Total Assets $34.67M $39.67M $39.67M
YoY Change -42.78% -42.58% -42.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.055M $1.716M $1.716M
YoY Change 279.85% 225.62% 225.62%
Accrued Expenses $10.50M $200.0K $1.101M
YoY Change 373.83% -34.21% -57.36%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $12.65M $3.699M $3.699M
YoY Change 199.2% -8.82% -8.82%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.65M $3.699M $3.699M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $12.65M $3.699M $3.699M
YoY Change 192.15% -9.0% -9.0%
SHAREHOLDERS EQUITY
Retained Earnings -$131.0M -$204.8M
YoY Change -26.94% 21.05%
Common Stock $153.0M $240.8M
YoY Change 2.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $22.02M $35.97M $35.97M
YoY Change
Total Liabilities & Shareholders Equity $34.67M $39.67M $39.67M
YoY Change -42.78% -42.58% -42.58%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$19.29M -$7.403M -$35.61M
YoY Change 90.05% -14.66% -0.6%
Depreciation, Depletion And Amortization $13.00K $0.00 $300.0K
YoY Change -89.34% -100.0% -42.2%
Cash From Operating Activities -$5.355M -$5.073M -$22.88M
YoY Change -17.92% -43.35% -27.37%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $308.0K
YoY Change -100.0% -36.89%
Acquisitions
YoY Change
Other Investing Activities $4.750M $12.26M $27.27M
YoY Change 212.5% 13.62% 142.6%
Cash From Investing Activities $4.750M $12.26M $26.96M
YoY Change 212.5% 13.67% 150.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 23.52M -53.00K -139.0K
YoY Change -165.43% -120.0%
NET CHANGE
Cash From Operating Activities -5.355M -5.073M -22.88M
Cash From Investing Activities 4.750M 12.26M 26.96M
Cash From Financing Activities 23.52M -53.00K -139.0K
Net Change In Cash 22.91M 7.134M 3.940M
YoY Change -557.83% 273.12% -119.65%
FREE CASH FLOW
Cash From Operating Activities -$5.355M -$5.073M -$22.88M
Capital Expenditures $0.00 $0.00 $308.0K
Free Cash Flow -$5.355M -$5.073M -$23.19M
YoY Change -17.92% -43.32% -27.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001534133
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-39538
CY2022 dei Entity Registrant Name
EntityRegistrantName
GRAYBUG VISION, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-2120079
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
274 Redwood Shores Parkway
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
P.O. Box 144
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Redwood City
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94065
CY2022 dei City Area Code
CityAreaCode
650
CY2022 dei Local Phone Number
LocalPhoneNumber
487-2805
CY2022 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2022 dei Trading Symbol
TradingSymbol
GRAY
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
13000000.0
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
21997030
CY2022 dei Auditor Firm
AuditorFirmId
42
CY2022 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2022 dei Auditor Location
AuditorLocation
San Mateo, California
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17304000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13364000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
21824000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
50306000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
542000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3408000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
39670000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
67078000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1981000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
29000
CY2022Q4 us-gaap Assets
Assets
39670000
CY2021Q4 us-gaap Assets
Assets
69088000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
200000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1716000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
527000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
304000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
203000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1580000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3226000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3699000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4057000
CY2021Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
8000
CY2022Q4 us-gaap Liabilities
Liabilities
3699000
CY2021Q4 us-gaap Liabilities
Liabilities
4065000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21696433
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21696433
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21357773
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21357773
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
240799000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
234225000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-204793000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-169188000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-37000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-16000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
35971000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
65023000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
39670000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
69088000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14113000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18903000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19104000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17044000
CY2022 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
2963000
CY2022 us-gaap Operating Expenses
OperatingExpenses
36180000
CY2021 us-gaap Operating Expenses
OperatingExpenses
35947000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-36180000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-35947000
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
575000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
126000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-35605000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22879000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31500000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
308000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-35821000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.66
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.66
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.69
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.69
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21489280
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21489280
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21199291
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21199291
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-35605000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-35821000
CY2022 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-21000
CY2021 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-12000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35626000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35833000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
94786000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
695000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5375000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-35821000
CY2021 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-12000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
65023000
CY2022 gray Adjustments To Additional Paid In Capital Issuance Of Common Stock Upon Vesting Of Restricted Stock Units Net Of Shares Withheld For Employee Taxes
AdjustmentsToAdditionalPaidInCapitalIssuanceOfCommonStockUponVestingOfRestrictedStockUnitsNetOfSharesWithheldForEmployeeTaxes
139000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6713000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-35605000
CY2022 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-21000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
35971000
CY2022 us-gaap Profit Loss
ProfitLoss
-35605000
CY2021 us-gaap Profit Loss
ProfitLoss
-35821000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
6713000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
5375000
CY2022 us-gaap Depreciation
Depreciation
338000
CY2021 us-gaap Depreciation
Depreciation
519000
CY2022 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-97000
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
277000
CY2022 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
319000
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-58000
CY2022 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
2194000
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1599000
CY2022 gray Increase Decrease In Prepaid Expenses And Other Current And Noncurrent Assets
IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets
-2895000
CY2021 gray Increase Decrease In Prepaid Expenses And Other Current And Noncurrent Assets
IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNoncurrentAssets
-1378000
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1304000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2052000
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-104000
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1052000
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-380000
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-1888000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
488000
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
35569000
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
95000
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
94570000
CY2022 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
64349000
CY2021 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
105809000
CY2022 us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
1944000
CY2022 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
430000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
26958000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10751000
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
139000
CY2022Q1 gray Operating Lease Right Of Use Assets
OperatingLeaseRightOfUseAssets
600000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
600000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
695000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-139000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
695000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3940000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-20054000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13364000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
33418000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17304000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13364000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
567000
CY2022 gray Acquired In Process Research And Development In Accrued Liabilities
AcquiredInProcessResearchAndDevelopmentInAccruedLiabilities
250000
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
115000
CY2022Q3 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.71
CY2022 us-gaap Restructuring Charges
RestructuringCharges
3000000.0
CY2022Q4 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
20
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-204800000
CY2022Q3 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.71
CY2022Q4 gray Number Of Remaining Programs
NumberOfRemainingPrograms
2
CY2022Q4 gray Number Of Remaining Employees
NumberOfRemainingEmployees
8
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting periods. Actual results could differ from those estimates. Significant items subject to estimates include estimates related to accrued research and development expenses, contingent milestone payments, other long-lived assets, stock-based compensation, incremental borrowing rates for leases and the valuation of deferred tax assets. The Company bases its estimates using historical experience, Company forecasts and future plans, current economic conditions, and information from third-party professionals that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities and recorded amounts of expenses that are not readily apparent from other sources, and adjusts those estimates and assumptions when facts and circumstances dictate.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company’s results can also be affected by economic, political, legislative, regulatory and legal actions. Economic conditions, such as recessionary trends, inflation, interest, changes in regulatory laws and monetary exchange rates, and government fiscal policies, can have a significant effect on operations. While the Company maintains reserves for anticipated liabilities, the Company could be adversely affected by civil, criminal, regulatory or administrative actions, claims, or related proceedings.</span></p>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Concentrations of Credit Risk and Off-balance Sheet Risk</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial instruments that potentially subject the Company to a concentration of credit risk consist primarily of cash and cash equivalents and available-for-sale marketable securities. The Company’s investment policy includes guidelines regarding the quality of the financial institutions and financial instruments and defines allowable investments that the Company believes minimizes the exposure to concentration of credit risk. The Company may invest in money market funds, U.S. Treasury securities, corporate debt, U.S. government-related agency securities, commercial paper and certificates of deposit. At December 31, 2022 and 2021, the Company’s cash and cash equivalents were held in financial institutions that management believes are creditworthy. These deposits may exceed federally insured limits. The Company has not experienced any losses historically in these accounts and believes it is not exposed to significant credit risk in its cash and cash equivalents. The Company has no significant off-balance sheet concentrations of credit risk, such as foreign currency exchange contracts, option contracts, or other hedging arrangements.</span></p>
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
12374000
CY2022Q4 gray Short Term Investment Fair Value Disclosure
ShortTermInvestmentFairValueDisclosure
21824000
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
34198000
CY2021Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
13149000
CY2021Q4 gray Short Term Investment Fair Value Disclosure
ShortTermInvestmentFairValueDisclosure
50306000
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
63455000
CY2022Q4 gray Fair Value Assets Transfers Amount Between Levels1 And2
FairValueAssetsTransfersAmountBetweenLevels1And2
0
CY2022Q4 gray Fair Value Liabilities Transfers Amount Between Levels1 And2
FairValueLiabilitiesTransfersAmountBetweenLevels1And2
0
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2022 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2022Q4 gray Number Of Short Term Investments In Unrealized Loss Positions
NumberOfShortTermInvestmentsInUnrealizedLossPositions
12
CY2022 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
0
CY2021 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
0
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3634000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1653000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1981000
CY2022 us-gaap Depreciation
Depreciation
300000
CY2021 us-gaap Depreciation
Depreciation
500000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
503000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1866000
CY2021Q4 gray Prepaid Clinical And Research Expenses Current
PrepaidClinicalAndResearchExpensesCurrent
168000
CY2022Q4 gray Interest And Other Receivables Current
InterestAndOtherReceivablesCurrent
39000
CY2021Q4 gray Interest And Other Receivables Current
InterestAndOtherReceivablesCurrent
21000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1353000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
542000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3408000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
698000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2278000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
431000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
461000
CY2022Q4 gray Holdback Liability For Acquisition Of In Process Research And Development
HoldbackLiabilityForAcquisitionOfInProcessResearchAndDevelopment
250000
CY2022Q4 gray Severance And Termination Benefits
SeveranceAndTerminationBenefits
124000
CY2022Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
77000
CY2021Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
479000
CY2021Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
8000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1580000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
3226000
CY2022Q4 gray Number Of Contract Currently In Effect
NumberOfContractCurrentlyInEffect
1
CY2022Q4 gray Contractual Obligation Of Contract In Effect
ContractualObligationOfContractInEffect
1300000
CY2022 gray Unpaid Cancellation And Other Related Costs
UnpaidCancellationAndOtherRelatedCosts
0
CY2022Q4 us-gaap Contractual Obligation
ContractualObligation
9100000
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
500000
CY2022 us-gaap Variable Lease Cost
VariableLeaseCost
500000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
527000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
205000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
732000
CY2022 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
2200000
CY2022 gray Development Or Regulatory Milestones Were Deemed Probable Of Achievement
DevelopmentOrRegulatoryMilestonesWereDeemedProbableOfAchievement
0
CY2022 gray Contingent Payments Recognized
ContingentPaymentsRecognized
0
CY2022Q4 gray Number Of Litigation Complaints
NumberOfLitigationComplaints
4
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.33
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
665132
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4352440
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.49
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1599000
CY2022 us-gaap Severance Costs1
SeveranceCosts1
1065000
CY2022 us-gaap Other Restructuring Costs
OtherRestructuringCosts
299000
CY2022 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
2963000
CY2022 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
300000
CY2022Q4 gray Net Book Value Of Capital Equipment Before Impairment
NetBookValueOfCapitalEquipmentBeforeImpairment
1659000
CY2022Q4 gray Fair Value Of Capital Equipment
FairValueOfCapitalEquipment
-350000
CY2022 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
1309000
CY2022 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
290000
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1599000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3777398
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.58
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y4M24D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
42000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1240174
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.94
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
11500000
CY2022 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M12D
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y9M18D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2399117
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.87
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y1M6D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2500000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.96
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.72
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.87
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.88
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.87
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.88
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0162
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0291
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0084
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0112
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6713000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5375000
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.025
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.006
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.017
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.014
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.053
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.004
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.149
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.226
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
38253000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
34431000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
5071000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
5408000
CY2022Q4 gray Deferred Tax Assets Deferred Expense Capitalized Research And Development Costs
DeferredTaxAssetsDeferredExpenseCapitalizedResearchAndDevelopmentCosts
2323000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
882000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1408000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
46529000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
41247000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
46529000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
41215000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
32000
CY2021Q4 gray Deferred Income Tax Liabilities Depreciation
DeferredIncomeTaxLiabilitiesDepreciation
32000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
32000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
5300000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
175200000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
23800000
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21489280
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21199291
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
21199291
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2090000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1981000
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
155000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
257000
CY2022 gray Unrecognized Tax Benefits Increase Decrease Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions
-275000
CY2021 gray Unrecognized Tax Benefits Increase Decrease Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreaseDecreaseResultingFromPriorPeriodTaxPositions
-148000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1970000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2090000
CY2022 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-35605000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-35821000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.66
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.66
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.69
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.69
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
21489280

Files In Submission

Name View Source Status
0000950170-23-006795-index-headers.html Edgar Link pending
0000950170-23-006795-index.html Edgar Link pending
0000950170-23-006795.txt Edgar Link pending
0000950170-23-006795-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gray-20221231.htm Edgar Link pending
gray-20221231.xsd Edgar Link pending
gray-ex10_17.htm Edgar Link pending
gray-ex23_1.htm Edgar Link pending
gray-ex31_1.htm Edgar Link pending
gray-ex31_2.htm Edgar Link pending
gray-ex32_1.htm Edgar Link pending
gray-ex32_2.htm Edgar Link pending
img42518119_0.jpg Edgar Link pending
img42518119_1.jpg Edgar Link pending
img42518119_2.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gray-20221231_cal.xml Edgar Link unprocessable
gray-20221231_def.xml Edgar Link unprocessable
gray-20221231_lab.xml Edgar Link unprocessable
gray-20221231_pre.xml Edgar Link unprocessable
gray-20221231_htm.xml Edgar Link completed
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending